On the other hand, although antiangiogenic agents, especially anti-VEGF ones, are originally designed to prune the tumor’s neo-vasculature, they have recently been found to render normalization of the makeshift tumor vasculature by pruning mainly abnormal vasculature but leaving the good ones behind. This evidence concerns the gene VEGFA and neoplasm.